
- /
- Supported exchanges
- / US
- / LIVN.NASDAQ
LivaNova PLC (LIVN NASDAQ) stock market data APIs
LivaNova PLC Financial Data Overview
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; and devices that deliver neuromodulation therapy for treating difficult-to-treat depression and drug-resistant epilepsy. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get LivaNova PLC data using free add-ons & libraries
Get LivaNova PLC Fundamental Data
LivaNova PLC Fundamental data includes:
- Net Revenue: 1 275 M
- EBITDA: 225 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-29
- EPS/Forecast: 0.49
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
LivaNova PLC News

Interesting LIVN Put And Call Options For September 19th
Investors in LivaNova PLC (Symbol: LIVN) saw new options become available today, for the September 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the LIVN o...


Jefferies Reiterates a Buy Rating on LivaNova PLC (LIVN) With a $79 PT
LivaNova PLC (NASDAQ:LIVN) is one of the best undervalued medical device stocks to buy now. On June 6, Jefferies analyst Matthew Taylor maintained a Buy rating on LivaNova PLC (NASDAQ:LIVN) and set a ...

LivaNova to Announce Second-Quarter 2025 Results
LONDON, July 09, 2025--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2025 results on Wed., Aug. 6...

Are Options Traders Betting on a Big Move in LivaNova Stock?
Investors in LivaNova PLC LIVN need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 18, 2025 $32.50 Put had some of the highest implied volatil...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.